刚刚！IPO审4过4

Group 1 - The article discusses the approval of four companies for IPOs, with one from the Shenzhen Main Board, one from the ChiNext, and two from the Beijing Stock Exchange [1] - The companies approved include: - Fuen Co., Ltd. focusing on eco-friendly fabric research and sales, projected revenue of 181.28 million and net profit of 25.48 million for 2024 [2] - Sanrui Intelligent Technology Co., Ltd. specializing in drone electric power systems, with projected revenue of 83.15 million and net profit of 32.05 million for 2024 [3] - Xinhengtai New Materials Co., Ltd. focusing on functional polymer foam materials, with projected revenue of 77.42 million and net profit of 8.20 million for 2024 [4] - Puang Medical Technology Co., Ltd. engaged in diabetes care and medical devices, with projected revenue of 31.83 million and net profit of 6.69 million for 2024 [4] Group 2 - Fuen Co., Ltd. has a total of 17.5 million shares before the IPO and is controlled by Paiya Holdings with a 36.57% stake, while the actual controllers hold 83.89% of the shares [5][6] - The company reported revenues of 176.38 million, 151.69 million, 181.28 million, and 93.81 million over the past four years, with net profits of 27.57 million, 22.68 million, 25.48 million, and 10.01 million respectively [7] Group 3 - Sanrui Intelligent Technology Co., Ltd. has a total of 36 million shares before the IPO and is controlled by Wu Min with 81.06% voting rights [13][14] - The company reported revenues of 36.16 million, 53.38 million, 83.15 million, and 43.56 million over the past four years, with net profits of 10.09 million, 16.18 million, 32.05 million, and 15.31 million respectively [15] Group 4 - Xinhengtai New Materials Co., Ltd. has a total of 12.33 million shares before the IPO and is controlled by Chen Chunping and Jin Wei with a combined 75.04% voting rights [21][22] - The company reported revenues of 53.00 million, 67.93 million, 77.42 million, and 38.43 million over the past four years, with net profits of 3.97 million, 9.34 million, 8.20 million, and 4.68 million respectively [23] Group 5 - Puang Medical Technology Co., Ltd. has a total of 4.23 million shares before the IPO and is controlled by Tai You Hong and Pu Mao Partnership with a combined 54.67% stake [27][28] - The company reported revenues of 24.18 million, 23.65 million, 31.83 million, and 17.83 million over the past four years, with net profits of 5.16 million, 4.21 million, 6.69 million, and 4.31 million respectively [30]